MedtronicTalks

In this episode of the MedtronicTalks Podcast, Frank Chan, president of patient monitoring, explains how the pressures of the pandemic accelerated Medtronic’s development of patient monitoring systems that allowed for remote connection between caregiver in patient. Chan says Medtronic isn’t losing any momentum in rolling out new approaches to tracking patient health, projecting that the next five to 10 years promises “significant changes” to how vital signs and other critical measures will be reported.

In this episode of MedtronicTalks, Dan Wolf, vice president and general manager of Intelligent Data Solutions, sits alongside Thomas Mosnier, research director, iDS, to detail Medtronic’s continued build out of its cranial and spine business. The iDS business, which includes Medicrea, brings applications of artificial intelligence and predictive modeling to spine surgery as well as patient-specific implants. How is the spinal surgery community responding and where does Medtronic see this technology moving forward?

In this opening episode of Season 2 of MedtronicTalks, Dr. Sally Saba, MD, details her work as the company’s first Chief Inclusion & Diversity Officer. Saba joined Medtronic in March 2020, two months before the murder of George Floyd emphasized the importance of building a more accepting culture. Saba recalls her own journey toward feeling accepted and details her transition from physician to healthcare executive to DE&I champion. She also reviews Medtronic internal report on its how well it’s doing to build a stronger culture.

In this episode of MedtronicTalks, John Mack, president of cardiac surgery, reflects on his 26-year career at the company and reviews the technologies that support and repair damaged hearts. Mack discusses advances in CABG, ablation and extracorporeal life support as well as his work in the heart patient community.

In this episode, Jason Weidman, SVP and President of Coronary & Renal Denervation at Medtronic, says he’s doing exactly what he set out to do when he became an engineer over 20 years ago, creating lifesaving medical devices. Weidman is leading Medtronic’s push to secure FDA approval for Medtronic Symplicity Spyral™ RDN system, which uses renal denervation to reduce hypertension. Medtronic’s clinical trials of Symplicity have been among the most closely watched - and most difficult to execute - in the industry. Weidman will discuss the challenges while also sharing his reasons for optimism.

A life-saving intervention for his newborn son convinced David Moeller to steer his career into Medtech. Now, as senior vice president and president of Peripheral Vascular Health, he oversees Medtronic’s peripheral vascular group which helps keep blood flowing to the body’s vital organs. In this episode, Moeller lays out the health crisis brought on by poor vasculature and how Medtronic is targeting five critical areas to help people live fuller lives.

In this episode, Nina Goodheart, president of Medtronic’s Structural Heart and Aortic Operating Unit, takes listeners – valve by valve – through Medtronic’s growing toolkit of replacement heart valves, an increasingly competitive space in medtech. Goodheart also talks to the company’s commitment to ensure greater access to better healthcare. Goodheart, so-chair of the Medtronic Women’s Network, also speaks to the importance of opening doors for female executives.

Following the company-wide reorganization, Surgical Innovation emerged as Medtronic’s large operating unit. In this episode, Matt Perry, president of the group, explains where the business will find future growth. At least some of that will come through digital effort like the GoFurther app, which connects bariatric surgeons with their patients. Dr. Marina Kurian joins the interview to explain how the app is streamlining the process patients must go through undergo the life-changing procedure.

In this episode, Vince Racano, president of Medtronic's Ear, Nose and Throat business, lays out the growth plan for this burgeoning business. Racano updates listeners on the announced acquisition of publicly traded Intersect ENT. He explains how the company will fit into Medtronic’s ENT franchise.

Julie Brewer, president of the Cardiovascular Diagnostics and Services, explains why Medtronic carved out a data-oriented business to form tighter connections with patients. Brewer explains how advances in manufacturing and data-collection can position the business at the center of the digital health space.